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INTRODUCTION 
Head and Neck cancer is one of the most common cancers in our country 
and Oral cavity is the commonest site among these cancers   constituting 30 % of 
the total. Nearly half of the patients are in locoregionally advanced stage at the 
time of presentation. This same trend prevails in our hospital also. Mortality in 
Head & Neck cancers is mostly due to uncontrolled locoregional disease. 
Therefore control of locoregional disease becomes the cornerstone of treatment 
in such patients which involves multimodal approach in the form of Surgery and 
Radiotherapy. Surgery often has to be extensive in nature with Radiotherapy 
added preoperatively most of the time. This extensive resection needs complex 
reconstructive procedures.  Hence the resultant morbidity is not only from the 
disease itself but also significantly from the consequences of these aggressive 
treatments   
 Head and Neck region, the most important part of the body cosmetically, 
is also the sheet anchor of important basic functions of life like chewing, 
swallowing and speech. Surgery often results in acceptable to devastating 
morbidities in terms of function and cosmesis. The affected functions are mouth 
opening, oral competence, occlusion, speech and swallowing. The role of 
oncological care does not stop with surgery alone but involves the effective 
rehabilitation of these functional problems thereby improving the quality of life. 
Nowadays the outcome of treatment is not only assessed with over all survival 
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and Disease Free interval but also with assessment of Quality of life (QOL) 
following treatment. Hence outcome of treatment of oral cancer with good 
survival but without acceptable functional outcome is  meaningless.  
   Now microvascular reconstructive procedures, osseointegrated implants 
and improved prosthesis have reduced the morbidity to a great extent. But most 
important result is the post operative functional rehabilitation which requires 
dedicated multidisciplinary team. To plan and focus the rehabilitative measures 
it is important to accurately assess the type and degree of impairment. 
The available tests to assess the functions like speech and swallowing are 
time consuming; costly; needs technical experts, not available everywhere and 
have poor patient compliance. Right now there is no universally acceptable 
clinical assessment system.  
Our patients belong largely to low socio economic group with poor 
intelligence and come from places which are far away. With this background we 
devised this simple scoring system based on clinical methods to assess the 
functional outcome  which can be applied in the outpatient department itself. 
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AIMS OF THE STUDY 
 To evolve a simple assessment system for assessing the functional 
outcome of oral cancer resection based on clinical methods which can be 
applied at the Outpatient department itself   
 To assess the psychosocial impact of the Morbidity. 
 To assess the correlation of functional impairment to the type and extent 
of resection.  
 To assess how the patient adapts to the impairment over the period of 
time.   
 To assess the priority of Rehabilitation needs. 
 To assess the reconstructive efficacy of our surgery. 
 And ultimately assessing the over all quality of life following Surgery and 
how this scoring system is useful in our setup and our set of patients 
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MATERIALS 
It is a prospective study during the period between 2000 January to 2004 
December. Patients with oral cancers with out distant metastasis who underwent 
different types of oral resections and reconstructions were included in the study. 
This includes those who received Preoperative RT also. Patient who developed 
recurrence were excluded from the study. Similarly those who are not coming 
for follow up regularly during one year also excluded. 
Patient with resection extending to oropharynx and supraglottic larynx 
also excluded from the study. Patient with flap failure and patient who 
underwent immediate recorrection also excluded. 
Total number of cases during this period is   101 
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METHODS 
Patients were taken up for surgery after metastatic workup. Extent of 
resection and type of reconstruction were planned in the preoperative planning 
session after getting consent from the patients.All the patients were thoroughly 
counselled about the morbidity in terms of function and the need for 
rehabilitative training and regular follow-up. 
            Dental care and mouth hygiene taken care off by the dentist when the 
patients are planned for pre operative RT 
Break up of lesion: 
 
 
 
 
 
 
 
 
 
 
 
 
8
39
30
24
Lip Cheek Tongue Alveolus
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We have devised a classification of Resection based on the impairment of 
function it produces. 
Types Resection Impairment 
I Cheek , Lip Oral competence 
II Maxilla, Mandible Speech, Occlusion 
III Tongue/And floor of mouth Speech, Swallowing 
IV Combined Combination 
 
No. Cases studied between 2000- 2004:                 101 
Type I Resection (Cheek , Lip ) 15 14.85% 
Type II Resection ( maxilla, mandible) 14 13.86% 
Type III Resection (Tongue) 12 11.88% 
Type IV Combined 60 59.40% 
 
Preop RT:   
 
 
 
 
 
 
 
 
PREOPERATIVE RT
Type I
10%
Type 2
14%
Type 3
7%
Type 4
69%
Type I Type 2 Type 3 Type 4
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Reconstruction:          
We have done reconstruction in all cases except in Type III resection  
where wide local excision of tongue  or  hemiglossectomy done with primary 
closure .These procedures were  done  in lesions limited to the tongue without  
involving the  floor of mouth. 
Flaps used are:  
Pectoralis Major Myocutaneous Flap 
Fore Head Flap 
Nasolabial Flap 
Deltopectoral flap 
wide excision and  split skin grafting done in select cases of cheek lesion. 
Reconstruction with Pectoralis Major Myocutaneous flap and Deltopectoral flap 
were done for composite resection and Fore head flap and Nasolabial Flap were 
used for cheek and lip reconstruction. 
Microvascular free flaps are not routinely done in our centre. 
Following are the parameters taken for assessment. 
1. Pain 
2. Mouth Opening 
3. Oral Closure 
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4. Occlusion 
5. Swallowing 
6. Speech 
7. Cosmetic/Social acceptance 
Each function is given a score ranging from 5 to 0 depending on the 
impairment.  A score of 5 means excellent and 0 meaning poor result. 
Assessment is done by interacting with the patient, and sometimes with 
the attendant and by observing the acts of swallowing, mouth opening, closure 
and speech. 
Functional assessment done at the time of discharge when the wounds 
have healed completely, after 3 months and at the end of one year 
For example pain is assessed as follows 
No pain - Excellent (5) 
Rare pain – Good (3) 
Modest    -Fair (1) 
Severe pain – poor (0) 
Similarly each function is assessed and is given in the following Table in 
detail 
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Royapettah Scoring System 
Ratings Excellent(5) Good(3) Fair(1) Poor(0) 
Pain Nil Rare Modest Severe 
Mouth Opening Normal Trismus + Trismus + + Trismus +++ 
Oral Closure Blows Holds Food Rare Spill Drooling of Saliva 
Occlusion Hard Bite Chews Solid Soft Solid Liquid Only 
Swallowing Normal Avoids certain food Regurgitation Aspiration 
Speech Normal Few Syllables Audible Not Audible 
Cosmetic/Social 
Acceptance 
Resumes Work 
Enthusiastically 
Adapts to Work Socializes  & 
Accepts 
Confines and Dislikes 
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Thus the maximum scoring we get is 35.  A score of less than 17 is taken 
as poor result.  One year score is taken as final one and further treatment is 
planned accordingly, (Because local recurrence is common within one year). 
Outcomes of surgery are divided based on the total scoring as follows 
Excellent >30 
Good 25-30 
Fair 17-24 
Poor <17 
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ANALYSIS 
The analysis is done function wise 
ORAL CLOSURE/ORAL COMPETENCE 
Oral closure /Oral competence is the commonly affected function in our 
series. In cases reconstructed with nasolabial flap minimal impairment with good 
outcome were noticed whereas in fore head reconstruction the results were Good 
to Fair outcome. Composite resection resulted in fair to poor outcome in the 
form of spilling of food and drooling of saliva. Most patients with food spill 
adapted to the condition and improved over time whereas patients with drooling 
of saliva found it very difficult to adapt. These patients were advised flap 
revision after one year. But only 15 % of patients accepted and underwent flap 
revision 
CHEWING/OCCLUSION 
Chewing/occlusion is the most severely affected as almost 60 % of patient 
underwent composite resection where one hemimandible is removed. Hard bite 
is completely affected  
(Marginal and segmental mandibulectomy not routinely done as most 
patient are presenting with advanced lesion and 73 % patients of composite 
resection received  preop RT)  
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Chewing is worst affected where both maxilla and mandible were 
removed and also in resection of mandible extending to mentum. But most 
patients were able to chew solid food with opposite side. Some patients modified 
their food habits. 
SPEECH 
Speech impairment was more pronounced in composite resection group 
where hemiglossectomy or total glossectomy is included in the resection. It is 
also high in groups of people who underwent palatoalveolar excision and 
maxillectomy. 
SWALLOWING 
Swallowing is also affected in all cases from minimal degree to a greater 
extent except in Type I resection. Patient who underwent wedge resection of 
tongue or Hemiglossectomy had swallowing difficulty but all patients improved 
very well over a period of time. Swallowing is affected more when the floor of 
mouth was also included in the resection. 
COSMESIS AND SOCIAL ACCEPTANCE 
Cosmetic outcome is fair to poor in our series because of our handicaps in 
reconstruction. Microvascular free flap not done routinely, segmental and 
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marginal mandibulectomy are rarely done in view of advanced lesion and 
preoperative RT in most cases.   
In spite of cosmetic disfigurement, social acceptance is very high in our 
patient group. Only three patients complained very much about the cosmesis and 
confined themselves to home.The increased acceptance is being due to the rural 
background and low socioeconomic status.  
Obviously Functional impairment were more in composite resections and 
who received pre operative RT especially in composite resection group.  
Some kind of Improvement in these impairments is noticed in all patients 
during the follow-up. All patients are painless after one year.  But  mouth 
opening is progressively deteriorated in spite of effective rehabilitative training 
in about 22% of patients .All these patients have received  Preoperative RT. 
Swallowing and chewing were all very well improved by rehabilitative 
training and patients adaptation. Speech also improved in patients who are 
educated and motivated and those who regularly attend speech therapy. 
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In our series we had following results. 
 
Excellent 11.76% 
Good  41.8% 
Fair 28.22% 
Poor  18.87% 
 
 
Surgical correction in the form of flap revision and contraction release 
were done for oral incompetence and microstomia respectively after one year. 
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                                                        CONCLUSION 
The criteria we have laid down for the extent of impairment is simple and 
clear to follow  with minimal bias between the observers. Patient compliance is 
also very good for this assessment  
MERITS OF THE SYSTEM 
 Simple 
 Easy Applicability 
 Quick Assessment 
 Done at the Outpatient Department itself 
 No investigations and Good patient compliance 
 Therefore our Royapettah Scoring system is a simple clinical and cost 
effective method. It gives an effective assessment of functional outcome in our 
series of patients and we plan rehabilitation therapy based on that and found it 
very useful to our patients. 
FUTURE 
It needs to be compared with established functional tests and scoring 
systems to assess the impairment. Preoperative functional scoring should also be 
done by same system and compared with the Post operative one. This system has 
to be evaluated separately for similar type of resection and patients of similar 
intelligence. 
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PROFORMA  
 
Name:       Age/Sex: 
Address 
 
 
 IP NO. :       CD No.: 
 DOA  :    DOS :   DOD : 
Site of Lesion  : 
Stage of Lesion  : 
HPE    : 
Previous Treatment  : 
 Surgery  : 
 Radiotherapy  : EBRT 
     Brachytherapy 
Pre Operative Treatment in our Hospital 
 EBRT 
 Brachytherapy 
Surgery : Type of Resection  : 
   Type of Reconstruction : 
Whether Neck dissection Combined  : 
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Duration of Hospital Stay  : 
Wound Healing   : 
Post op. HPE    : 
Post op. Adjuvant Treatment : 
Functional Assessment 
At Discharge  At 3 Months  At One Year 
Function Score  Function Score  Function Score 
Pain   Pain   Pain  
Mouth 
Opening 
  Mouth 
Opening 
  Mouth 
Opening 
 
Oral Closure   Oral Closure   Oral Closure  
Occlusion   Occlusion   Occlusion  
Swallow   Swallow   Swallow  
Speech   Speech   Speech  
Social 
Acceptance & 
Cosmesis 
  Social 
Acceptance 
& Cosmesis 
  Social 
Acceptance & 
Cosmesis 
 
Total   Total   Total  
 
Final outcome at one year.   : 
Revision Surgeries for Impairment : 
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LITERATURE REVIEW 
INTRODUCTION 
 The cosmetic, functional, and psychosocial results of oral cancer 
treatment may combine to produce devastating effects on patients, especially if 
the tumor is extensive or the treatment particularly aggressive. Indeed, oral 
cancer is noted for the toll it exacts from patients, from both the disease itself 
and the effects of its treatment. A variety of functions can be affected, including 
speech, deglutition, management of oral secretions, and mastication. . Most of 
these patients required to be rehabilitated at major teaching institutions or 
designated cancer centers that include a multidisciplinary team as their treatment 
may result in loss of oral functions and cosmetic deformities. 
 With recent changes in the modalities of cancer treatment and 
reconstruction (e.g., the introduction of brachytherapy and microvascular free 
flap transfers), rehabilitation of the oral tissues takes on a new dimension. 
Conventional maxillofacial prosthetic rehabilitation usually will not be enough 
to restore the resultant hard or soft tissue defects. Thus, a multidisciplinary 
surgical team that includes dentists will increasingly be instrumental in the 
reconstruction of head and neck patients. The ultimate goal of rehabilitation, 
however, will remain the restoration of oral functions and cosmesis with the aim 
of providing an acceptable quality of life. 
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 Successful rehabilitation and quality of life go hand in hand. Because 
patients vary in attitudes and adaptation, it is very difficult to predict the 
patient’s eventual quality of life prior to initiating treatment for an oral tumor. 
Furthermore, the use of newer techniques at surgical reconstruction makes the 
maxillofacial prosthodontist’s task even more challenging. It is important for the 
dental team to be experienced and to identify for the medical and surgical 
oncologists realistic goals and objectives for rehabilitation. At major cancer 
centers with rehabilitative teaching programs, it is not uncommon for the 
surgically resected head and neck patient to require 20-25 appointments for 
appropriate rehabilitative care in a 1-year period. 
 With multidisciplinary cancer therapy (ablative surgery, reconstructive 
surgery, radiation therapy, and/or chemotherapy) available, rehabilitative 
dentistry is essential for improving quality of life. Treatment plans for 
rehabilitative dentistry should be included in the overall cancer treatment plan; 
in many instances, the sequelae of ablative head and neck surgery and radiation 
therapy could be alleviated, minimized, or even eliminated altogether if there 
were appropriate planning for maxillofacial prosthetic and other dental 
interventions before treatment begins. 
The strategy and techniques of rehabilitation of a head and neck cancer 
patient are directly related to the location of the cancer and to the extent and type 
of surgical intervention and radiation modalities used. Oral carcinomas not 
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detected and evaluated in their early clinical stages usually invade contiguous 
structures, thereby setting the stage for extensive surgical procedures that are 
generally followed by radiation therapy. 
Removal of extensive segments of the tongue, floor of mouth, mandible, 
and hard and soft palate as well as the regional lymphatics usually mandates 
extensive rehabilitative management. Generally, maxillofacial prosthodonotists 
restore maxillary resections with obturator prostheses. However, in many 
instances a soft palate speech bulb-obturator retained in the maxillae (for 
restoration of velopharyngeal function) or a palatal augmentation prosthesis (if 
tongue function is lost) is required for optimal rehabilitation. Currently, 
rehabilitation of a maxillectomy and/or soft palate defect via an obturator 
prosthesis is most effective in restoring function. Recent advances in 
microsvascular free flap tissue transfers have been used successfully to 
reconstruct composite defects of the mandible, buccal mucosa, and tongue. 
Current rehabilitative practice is centered in five principles: The process 
of rehabilitation begins at time of initial diagnosis and treatment planning. 
1. The dentition should be preserved if possible. 
2. Rehabilitative treatment plans should be based on fundamental 
principles of prosthodontics, including a philosophy of preventive 
dentistry and conservative restorative dentistry. 
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3. Surgery before prosthetic rehabilitation may be indicated to 
improve the existing anatomic configuration after ablative cancer 
surgery, reconstructive surgery, and/or radiation therapy.  
4. Multidisciplinary cancer care is required to achieve the best 
functional, physical, and psychologic outcomes. 
The need to treat tumors expediently often delays planning for 
rehabilitation. However, without a highly interactive and dynamic dialogue 
among health care providers during the initial treatment planning process, efforts 
to provide optimal rehabilitative care are impaired. Other health professionals-
including 
social workers,  
vocational rehabilitation counselors,  
nurses, nutritionists, 
occupational therapists,  
physical therapists,  
speech pathologists, and  
dental hygienists-are also vital members of the team. Because a team of this 
breadth is not typically encountered in the community setting, comprehensive 
rehabilitation is best managed in a tertiary referral center or specialized cancer 
hospital. 
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Factors affecting the cancer surgical treatment plan for oral cancer 
patients include the following 
• Prognosis and systemic status of patient; 
• Potential size and site of defect; 
• Potential nature of functional and/or cosmetic defect; 
• Adjunctive therapy (e.g., chemotherapy or radiation) that may 
compromise the surgical result; and 
• Anticipated changes to function and cosmesis, based on the cancer 
surgery and the availability, accessibility, and cost of rehabilitative 
procedures. 
Planning for patients who need rehabilitation of the maxillofacial 
complex includes consideration of surgical defects associated with the maxilla, 
mandible, tongue, soft palate, and facial region, including the patient with a 
combined orofacial abnormality.  
Specific abnormalities result directly from the extent and nature of cancer 
treatment as well as the patient’s functional and psychological ability to respond 
to changes induced by therapy. Thus, rehabilitation may be directed to 
hypernasality, mastication and deglutition dysfunction, control of oral secretions, 
compromised interarch relations, speech deficits (tongue disarticulation), 
salivary gland dysfunction, and/or cosmetics. 
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In recent years there have been significant advances in some of the 
strategies for rehabilitating the oral cancer patient. These include fundamental 
qualitative improvements in biomaterials (including osseointegrated implants), 
microvascular free flap tissue transfers, and hyperbaric oxygen technology (by 
which gas highly concentrated in oxygen is delivered under increased pressure to 
patients). 
Still, long-term success depends in large measure on effective follow-up 
protocols. The traditional idea that a patient’s original maxillofacial prosthesis 
will adequately support his or her lifelong needs is no longer valid. The 
prosthesis needs ongoing evaluation, adjustment, and usually replacement over 
time. Most removable extraoral prostheses need to be remade every 2 to 3 years; 
removable intraoral maxillofacial prostheses require regular maintenance and 
generally need replacement every 5 to 7 years. In addition, the ongoing long-
term sequelae of radiation therapy for head and neck cancer require the dentist to 
keep the periodontium in optimal condition. Furthermore, restorations of 
abutment teeth used to retain an intraoral maxillofacial prosthesis must be sound 
and noncarious, and implant prostheses in this population require extensive 
maintenance for optimal functional results. 
The standard of care for patients receiving a palatal resection 
(maxillectomy, palatectomy and/or soft palate resection) includes three stages of 
maxillofacial prosthetic intervention. 
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1. Immediate placement of a surgical obturator prosthesis (inserted in 
the operating room, usually by the maxillofacial prosthodontist, at 
completion of surgery to separate the oral cavity from nasal 
cavities created by cancer surgery). 
2. Placement of a provisional or interim postsurgical obturator 
prosthesis (inserted after the surgical obturator and packing is 
removed 7 days postoperatively, worn in the postoperative healing 
period). 
3. Placement of a definitive postsurgical obturator prosthesis. 
OSSEOINTEGRATION 
Major technologic advances have occurred in recent years in 
osseointegration (the process by which natural bone attaches to the metal or 
ceramic component of an implant), thereby facilitating the use of dental 
implants. Branemark et al. have pioneered the modern-day use of this 
technology, in which implant materials capable of bearing forces produced 
during normal function interface both structurally and functionally with bone. 
Dental implants are now being used in both oral and extraoral settings and have 
significantly improved the restoration of both form and function to the oral and 
craniofacial region. Potentially, implant-borne prostheses can be used in the 
majority of intraoral and extraoral defects. However, in patients with intraoral 
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defects, the most useful implant sites usually are not within the radiation 
treatment volume. An emerging exception appears to be the case of fibula free 
flaps, where implants are used to restore segmentally resected mandibles prior to 
post-surgical radiation. For extraoral prostheses, bioadhesives have traditionally 
been used to enhance retention but they have considerable limitations. Indeed, 
patients and clinicians often become frustrated by the difficulty of achieving 
optimal effects with adhesives. Both experience and specialized education can 
improve the clinician’s ability to provide these components of extraoral and 
intraoral rehabilitative care. 
The characteristics of successful osseointegration include: (1) 
biocompatible implant materials; (2) non-traumatic, aseptic surgical procedures; 
(3) an initial healing period in which functional loading  of forces is deferred; 
and (4) stress-reducing prosthodontic procedures. Patients should be selected 
with great care, and proper maintenance and follow-up are imperative. 
Successful osseointegration can permit the restoration of masticatory function 
following mandibular fibula free flap microvascular  transfers. Osseointegration 
in the maxillary-resected patient and implant-retained facial prostheses have 
become acceptable in major cancer centers worldwide  
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A. Emerging Trends 
Rehabilitative practices for oral and maxillofacial surgery patients have 
made important advances  during the past several decades. Relevant research on 
biomaterials has been transferred directly to the clinical setting; these materials 
permit effective functional and cosmetic management of many patients with 
facial and intraoral defects who would otherwise experience lifelong 
disfigurement and dysfunction. In addition, important advances in imaging 
modalities, adhesives, implant materials; bone grafting, microvascular free flap 
tissue transfers, and hyperbaric oxygen have collectively enhanced rehabilitation 
outcomes. Still, these new modalities require outcome assessments to measure 
their effects on patient rehabilitation. 
Future clinical and laboratory research on the use of osseointegrated 
implants and other prostheses in the presence of irradiated bone is expected to 
continue to refine the selection criteria for patients. Although the concern about 
osteoradionecrosis as a theoretic risk in such settings is real, risk is minimal in 
the maxilla, even in segments receiving more than 6,000 cGy. Even in the 
mandible, the prime implant site (symphysis) is not usually included in the high-
dose field; if it is included, the dose is generally limited in the setting of field 
size reductions or use of brachytherapy. 
A history of high-dose radiation to oral bone does not per se eliminate 
prosthetic placement of osseoimplants at irradiated sites. Patients who have 
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previously undergone head and neck irradiation still may be candidates for 
osseointegrated implants. The most likely limiting factors appear to be the ability 
to maintain viable appositional bone associated with the implant and the problem 
of the patient with a poor prognosis for tumor control. Selection of patients for 
osseointegrated systems must be based on careful consideration of their biologic 
and psychologic status. Because long-term, comprehensive monitoring of patient 
status is essential, the patient must commit to periodic comprehensive oral 
evaluations. 
Both basic research and clinical experimentation with osseointegrated 
implants in irradiated bone must be priorities. In addition, planning for the future 
must include training adequate numbers of experienced professionals to meet the 
growing need for osseointegrated systems. It is important that educational 
training programs include the use of osseoimplants in irradiated bone to meet the 
evolving needs of the head and neck cancer patient. 
Strategies for improving the rehabilitation of the oral cancer patient and 
reducing the volume of rehabilitative services needed include addressing risk 
behavior and detecting oral malignancies early. Opportunities exist to do the 
following: 
• Enhance primary cancer management by adding new radiation 
protocols, using combined modality therapy, and reducing acute or 
chronic injury to normal, contiguous tissues 
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•  Continue to foster research related to the complete rehabilitation 
of the patient, including investigations on reconstructive 
techniques, timing of the rehabilitation process, implants, and 
prostheses; 
• Enhance professional education at the predoctoral and postdoctoral 
levels, so that the gold standard of multidisciplinary management 
becomes available to more patients; and 
• Establish graduate training programs that combine traditional 
specialties for more comprehensive rehabilitation of the head and 
neck cancer patient, e.g., maxillofacial prosthetics and clinical oral 
medicine. 
 Limited technology and standards of care to protect normal tissues 
while maximizing direct exposure of the tumor to cytoreductive 
interventions. 
 .Limited national fiscal resources to extend reimbursement 
coverage for rehabilitative care; prevailing trends are to maintain 
or even reduce the scope of current reimbursement. 
 Inadequate exposure to oncology principles in undergraduate 
dental and medical school curricula. 
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.Considerations for the research agenda include the following: 
• Improved radiation delivery systems that protect an increased 
percentage of normal oral hard and soft tissues Topical or systemic 
interventions to protect normal tissues or enhance healing of 
damaged tissues; 
• Improved technology for the placement of prostheses, including 
osseointegration in previously irradiated tissues; 
• Improved prevention and management of osteoradionecrosis, 
including enhanced hyperbaric oxygen therapy protocols or new, 
superior modalities that promote angiogenesis and 
neovascularization; 
• Health services research on the cost-effectiveness of current and 
emerging interventions; and 
• Oral function assessment designed to determine which strategies 
are most effective in rehabilitation and medically necessary 
dentistry. 
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REHABILITATION OF SWALLOWING AND SPEECH IN 
HEAD AND NECK SURGERY 
INTRODUCTION 
 The interrelated management of swallowing and speech disorders in 
patients with head and neck cancer dates back to more than 100 years ago when 
the first reported laryngectomy by Billroth and Gussenbuer in 1874 also 
included a report of fitting a patient with a pneumatic artificial larynx that 
introduced sound into the pharynx through a surgically created fistula. The 
fistula aided the patient in communication, and it also reduced the propelling 
force associated with swallowing. Since that time, attention to swallowing and 
communication skills has increased dramatically with the advent of numerous 
surgical procedures to preserve voice and speech in patients after treatment of 
cancer of the head and neck. 
The management of dysphagia began its modern era only recently in 1983 
with publication of Logemann's text on the evaluation and treatment of 
swallowing disorders. Logemann outlined the rationale for fluoroscopic 
assessment of swallowing disorders and the protocol for identifying the 
disordered phases of swallowing. This functional evaluation using the modified 
barium swallow (MBS) assessment protocol is rotted in the early work of 
Barelay, who in 1930 reported on the use of fluoroscopy to identify normal 
swallowing behavior. Many current surgical procedures as well as non surgical 
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therapies, including radiation and combined chemoradiation, used in the 
management of patients with cancer of the head and neck disrupt the natural 
swallowing patterns or compound already existing problems of swallowing 
caused by the disease process. Moreover, these oncologic procedures contribute 
to voice changes such as hoarseness and weak voice, altered resonance, and 
disorders of speech articulation. 
 The oral cavity, pharynx, and larynx share the functions of channeling 
expiratory air flow and voice upward and outward and propelling food, liquids, 
and medications downward into the esophagus and stomach. Because of this 
shared passage, the speech-language pathologist (SLP) who is uniquely trained 
in the anatomy, physiology, and neurology of the head, neck, and upper 
aerodigestive tract is the ideal person to coordinate the preoperative and 
postoperative rehabilitation of voice, speech, and swallowing for patients with 
head and neck cancer. The Head and neck Surgeon and the SLP maintain a close 
relationship during the rehabilitation period. 
 Measures of treatment efficacy and treatment effectiveness have shown 
that comprehensive management that begins before curative treatment 
maximizes recovery of swallowing function and improves quality of life 
following treatment for patients with cancer of the head and neck. 
Flexible laryngoscopy allows examination of the anatomy of the pharynx 
and larynx during quiet and forced respiration, coughing, speaking, and 
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swallowing. Symmetry, coordination, and range of movement of the base of 
tongue and pharyngeal walls should be noted as the endoscope is passed. 
Pooling of secretions or food residue in the vallecula or pyriform sinuses should 
also be noted. The laryngeal closure reflex may be tested by gently touching the 
epiglottis or aryepiglottic folds with the tip of the endoscope. This maneuver 
requires some experience in that the examiner should avoid eliciting a gag reflex 
or laryngospasm. This test is often deferred until the endoscopic examination 
and swallow assessment have been completed. Sensation of the vallecula and 
lateral pharyngeal walls also can be tested with this technique. Alternatively, 
more objective measures of the laryngeal closure reflex and the sensory function 
of the upper aerodigestive tract can be obtained with the use of a flexible 
flberoptic laryngoscope with sensory testing capability described. This test uses 
a specially designed instrument to deliver a pulse of air to the aryepiglottic fold 
or vocal fold and measures the threshold of response to the air pulse. 
FUNCTIONAL EVALUATION 
Although clinical assessment may identify some patients with swallowing 
disorders, it has been shown that clinical assessment is not highly predictive of 
aspiration. A complete assessment of swallowing includes one or more 
instrumental tests following the bedside clinical assessment. Functional tests of 
swallowing such as fiberoptic endoscopic evaluation of swallowing, (FEES), 
modified barium swallow (MBS), and scintigraphy, provide specific information 
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regarding aspiration and focus on the physiologic aspects of the total swallow 
behavior. MBS and FEES provide diagnostic information because they assess 
the swallowing of the patient under a variety of circumstances, employing 
boluses with different consistencies and varying positions of the neck. These 
tests assist the clinician in planning a therapeutic protocol and identifying 
compensatory maneuvers, as well as in designing diet modifications to be used 
in the treatment of the swallowing disorders. 
BEDSIDE CLINICAL EVALUATION 
A bedside evaluation is usually performed by an SLP experienced in the 
diagnosis and management of swallowing disorders. Interpretation of the oral 
motor examination, assessment of cognitive status, and observations of actual 
swallows constitute the clinical experience. Rarely is the bedside swallow 
assessment the final procedure for determining if a patient can safely begin oral 
nutrition. Rather, it should be considered the first step in advancing the patient to 
oral nutrition. 
MODIFIED BARIUM SWALLOW  
 The MBS is a multidisciplinary evaluation of the swallowing mechanism, 
usually performed by a radiologist in collaboration with the SLP. Candidates for 
a MBS include those patients presenting with dysphagia who have had a normal 
barium esophagogram, those with postoperative swallowing (following head and 
neck oncologic surgery). 
 34 
 MBS is the best way to evaluate the oral phase and the entire pharyngeal 
phase of swallowing. It provides detailed analysis of the coordination and timing 
of swallowing. Events that may cause dysphagia include abnormal movements 
of the tongue in forming the bolus and initiating deglutition, pooling of residual 
barium in the valleculae or pyriform sinuses, and aspiration of barium into the 
airway. MBS also provides information about the function of the upper 
esophageal sphincter. 
 Under fluoroscopic observation controlled by the radiologist, the patient 
ingests barium of varying consistencies under the direction of the SLP. The 
consistency of the barium is chosen to approximate the consistencies of food that 
a patient is likely to encounter in his or her daily diet. The initial consistency 
may be guided by the bedside evaluation. Pre selected barium consistency as 
well as normal food coated with barium can be prepared to better approximate a 
normal meal. 
 Frontal and lateral views are obtained during the MBS with the patient 
standing or sitting. Unlike the barium swallow, the MBS is purely dynamic; 
thus, it is recorded on videotape for review and may be used for patient 
education. 
 Entry of barium into the airway may be the most important information 
that the MBS can provide. The extent of aspiration, including the amount or 
percentage of bolus, and the most distal level of entry should be defined clearly. 
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The terms aspiration and penetration are not standardized. To complicate matters 
further, the terms glottic penetration and laryngeal penetration have also been 
used. Therefore, it is preferable that the location of the barium that extends 
farthest into the airway (i.e., subglottic, glottic, trachea, bronchi, lungs) be 
described. This may be as subtle as a coating of the laryngeal surface of the 
epiglottis or as obvious as gross inspiration of the barium into the lower trachea-
bronchial tree. As with the traditional barium swallow, reflux of barium into the 
nasopharynx should also be documented. 
 Observer should also note the patient’s response to the aspiration such as 
coughing or clearing of the throat, and the degree to which the barium is cleared 
out of the airway. “Silent” aspiration is defined as aspiration that fails to elicit a 
normal cough response. Silent aspiration cannot be detected during a clinical 
(bedside) swallowing examination, but it is readily apparent on the MBS. 
Abnormal motion of the epiglottis, diminished contractions of the pharyngeal 
constrictor muscles, and abnormal laryngeal elevation can all be identified on the 
MBS. 
FIBEROPTIC ENDOSCOPIC EVALUATION OF SWALLOWING  
 The assessment of swallowing using FEES requires the passage of a 
flexible fiberoptic endoscope into the nares and over the velum to a position 
above the epiglotis.43 Topical anesthesia is applied with the use of cotton-tipped 
applicators to avoid anesthetizing the pharynx. Velopalatine anatomy and 
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function can be evaluated before the endoscope is passed into the oropharynx. 
Before liquid or food is offered to the patient, the examiner notes the anatomic 
structures and observes the functions of the velum (sustained phonation, 
repeating “coca-cola”), epiglottis, and larynx. After several “dry swallows” have 
been evaluated, specific amounts of liquids and varying food consistencies 
treated with food dye are viewed as they pass the pharynx and larynx. The 
quantity of retained secretions present in the vallecula and hypopharynx is also 
noted. Pharyngeal and laryngeal functions should be documented with different 
consistencies and amounts of bolus, along with various changes of the position 
of the head. The supraglottic swallow and chin tuck strategies may also be used 
to identify the possible causes of dysphagia. During the time of airway closure, 
the swallow cannot be visualized because the pharyngeal walls contract over the 
bolus, collapsing the lumen over the endoscope  
 Monitoring of the bolus is possible only before and after the pharyngeal 
swallow. However, the bolus can be monitored as it enters into view from the 
oral cavity to the pharynx. The speed of the pharyngeal swallow, premature flow 
of food or liquid into the pharynx and larynx, and residual amounts of the bolus 
can all be visualized during this examination. Unlike with the MBS, the 
endoscope may remain in place for long periods of time, allowing the clinician 
to monitor the residual bolus and examine anatomic structures. Swallowing with 
the use of compensatory strategies and changes in neck position is easily 
accomplished while the endoscope is in place. FEES are more sensitive than 
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MBS in detecting pooling of oropharyngeal secretions and subtle abnormalities 
of the palate, pharynx, and larynx; it provides better anatomic information. It 
does not assess the oral phase and does not evaluate the upper esophageal 
sphincter or the esophageal phase of swallowing. 
 FEES may be particularly useful when a patient cannot be easily 
transported to a radiology unit, has a significant voice quality change, or has 
limited ability to follow directions. 
 A FEES may not be indicated for patients with extreme movement 
disorders, those who cannot tolerate the endoscope, and those who have a history 
of bronchospasm or laryngospasm. 
FEES-ST 
 Fiberoptic endoscopic evaluation of swallowing with sensory testing 
(FEES-ST) employs the standard FEES testing with the addition of sensory 
testing of the supraglottic mucosa to determine the presence of a sensory 
dysfunction in patients with dysphagia. For this test, an air pulse generator is 
used to send a pulse of air through a port in a specially designed flexible 
endoscope. Air pulses can be delivered to the supraglottic larynx and the 
hypopharynx. Sensory thresholds can then be determined by means of 
psychophysical testing methods. 
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SCINTIGRAPHY 
 Scintigraphy is typically performed in the nuclear medicine suite by 
trained personnel. When used to track movement of the bolus and to quantify the 
residual bolus in the orophyarynx, pharynx, larynx, and trachea, this test is done 
by having the patient swallow a small amount of a radionuclide material (such as 
technetium 99m) combined with liquid or food. A special camera (gamma 
camera) records images of the organs of interest over time to reveal a 
quantitative image of the transit along with metabolic aspects. 
 Because there is no time limit for this testing, scintigraphy can be used to 
identify trace aspiration and to quantify the aspiration over short or long time 
periods (e.g., delayed “postprandial” or “reflux aspiration”). Scintigraphy can 
also be used to calculate the transit time and residual pooling of a bolus in 
patients suffering degenerative neuromuscular disease, both before and after 
treatment. Perhaps the strongest indication for the use of scintigraphy is in 
identifying those patients with reflux aspiration and those patients who, despite 
limited aspiration, have the ability to clear the aspirate quickly, as well as those 
in whom the aspirate does not reach the distal airways-this revealing a subset of 
patients who may be fed by mouth. 
 Despite its objective quantitative analysis of aspiration, scintigraphy does 
not provide an adequate definition of the anatomy of the upper aerodigestive 
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tract. Scintigraphy is also more costly than videofluorography or FEES. For 
these reasons, it is not sued routinely. 
MAGNETIC RESONANCE IMAGING   
 High-speed magnetic resonance imaging (MRI), such as fast low-angle 
shot (FAST) or echoplanar imaging, has allowed a dynamic analysis of the 
pharyngeal phase of swallowing that was impossible with the use of 
conventional MRI. The pharynx, oral cavity, laryngeal lumen, and musculature 
can be evaluated during motion, allowing assessment of the swallowing 
mechanism.  
 During a FAST MRI, intravenous contrast is injected into the patient and 
the patient is given an oral contrast containing ferric ammonium sulfate as a food 
bolus substitute. Images are obtained as the bolus is moved from the oral cavity 
to the esophagus. This technique however, can assess the activity of the oral 
cavity and pharynx only during short periods of time. 
 MRI has the advantage of not exposing the patient to radiation. However, 
the temporal and spatial resolution of MRI is inferior to that with 
videofluoroscopy; thus, images with poor resolution are produced. MRI is 
costly, and swallowing in the supine position may not reflect the true 
physiologic mechanism of swallowing.  
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MANAGEMENT OF SWALLOWING DISORDERS  
 Preoperative treatment information may predict the severity and duration 
of post-treatment dysfunction. Moreover, speech and voice disorders before 
surgery, radiation, or chemoradiation should also be documented so that realistic 
post-treatment communication expectations can be outlined and swallowing 
exercises that may help to prevent long-term disability can be initiated.  
Surgical Treatment     
 The goals of surgical treatment are to enhance the compensatory 
mechanisms of the unaffected side and to improve the sphincteric function of the 
swallowing mechanism. In extreme cases, the surgery may be of a palliative 
nature and may separate the trachea from the esophagus to stop aspiration. 
Rehabilitation   
 Rehabilitation of patients with cancer of the head and neck requires a 
multidisciplinary team approach that includes the surgeon, medical oncologist, 
radiation oncologist, maxillofacial prosthodontist, SLP, physical therapist, and 
oncology nurse. The rehabilitation team coordinates treatment from the time of 
diagnosis to the completion of rehabilitation by way of tumor board meetings, 
planning conferences, and patient/family conferences. The SLP is a vital 
member of the team and is responsible for the evaluation, recommendations, and 
treatment of speech and swallowing disorders that are encountered in patients 
 41 
diagnosed with cancer of the head and neck. The goals of the SLP are to educate 
patients about their disorders, identify the safest diet, teach techniques to prevent 
aspiration, increase speech intelligibility, monitor progress during different 
phases of treatment, and report results of treatments to the management team. 
 To manage patients effectively, the SLP who has specialized training in 
speech and swallowing disorders must understand the critical components of the 
disease, type of and its impairments, reconstructive procedures and its 
effectiveness and how the disease affects communication and swallowing. The 
size, location, and extent of tumor must be identified so that possible treatments 
can be planned because each of these parameters directly affects speech and 
swallowing. The effects of radiotherapy, including xerostomia, mucositis, and 
tissue fibrosis, must be considered because they negatively affect swallowing 
and may also cause changes in the voice. These issues must be addressed before 
the time of treatment and during the short-and long-term follow-up stages. 
 The reconstructive technique used following resection of the tumor also 
affects swallowing function. Techniques using primary closure or split-thickness 
skin grafts tend to minimize dysphagia and speech impairaments compared with 
reconstructive procedures that introduce tissue from other parts of the body.. The 
lack of adequate blood supply and nerve function usually limits motion as well 
as decreases sensation and thus increases the possibility of poor oral, pharyngeal, 
or laryngeal control of secretions.  
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 Each of these issues, as well as the need for assistance in the management 
of patients’ environmental and social issues, underscores the need for a well-
trained SLP to be integrated into the head and neck team. The team must be 
aware that goals for speech and swallowing change during the different phases 
of treatment and that the timing of an intervention may affect the outcome. For 
some patients with small lesions, speech and swallowing goals are met relatively 
early following primary treatment; for others (e.g., those with extended 
supraglottic laryngectomy), extensive rehabilitation may take 6 months or longer 
Unfortunately, in some cases, patients do not recover normal swallow function 
and may need additional surgery to manage aspiration or may require a 
permanent feeding tube to meet nutritional needs. Others with permanent speech 
disability, such as those who have undergone total glossectomy, may require 
additional non oral communication devices. 
Anterior / Lateral Tongue Resection       
 Resection of lesions of the tongue often disrupts manipulation and 
transfer of the bolus. The severity depends on the extent of resection, the 
mobility of the residual portion, and the type of reconstruction. The lack of 
lingual propulsion reduces swallowing efficiency in foods with higher viscosities 
In a recent study by Furia and coworkers, patients who underwent a partial 
glossectomy exhibited an increase in oral transit time for paste foods, stasis in 
 43 
the oral cavity, a reduction of anteroposterior propulsion of the tongue, and an 
increase in the number of deglutitions to clear the valleculae 
 The degree of surgical resection has a significant effect on the degree and 
duration of swallowing dsyfunction. Patients with less than 50% resection of the 
tongue usually have temporary swallowing problems Patients with greater than 
50% resection experience more severe effects, such as decreased lingual 
propulsion and inadequate contact of the remaining tongue with the palate. With 
these patents, palatal augmentation with a palatal drop prosthesis may be 
required to reduce the volume in the oral cavity and to provide greater lingual 
contact with the palate. 
 Resection of lesions in the anterior oral cavity does not affect the 
pharyngeal stage of swallowing; however, if resection includes portions of the 
lateral pharyngeal wall, initiation of the pharyngeal swallow is delayed and 
weakened pharyngeal peristalsis causes residue that is often aspirated after the 
swallow is completed. Rehabilitation efforts begin with the choice of safest 
consistency for oral feedings. During the postoperative stage, most patients 
benefit from lover-viscosity food choices such as skim milk, Patients are taught 
maneuvers that will assist with bolus transfer. Range-of-motion exercises are 
practiced to achieve maximum movement from the remaining tongue. 
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Total Glossectomy     
 The tongue is a dynamic organ that is involved in the oral preparatory 
phase, the oral phase, and the beginning of the pharyngeal phase of swallowing. 
When patients undergo total glossectomy, all three phases of swallowing are 
affected.  
Anterior Floor Of The Mouth  
 Resection of the anterior floor of the mouth creates oral dysphagia 
because of impaired range of motion of the tongue. Postoperative edema 
prevents adequate manipulation of the bolus and transfer of certain 
consistencies. Patients are taught to place the bolus posteriorly in the oral cavity 
to improve oral transit time. Postoperatively, foods may be restricted to a 
consistency that flows. Thin liquids can be easily aspirated before the swallow 
owing to loss of oral control; therefore, thickened liquids are usually the best 
choice for patients after this type of surgery.  
Communication Following Head and Neck Surgery  
 Following surgery to one or more organs of the head or neck, 
communication may be impaired owing to problems of articulatior, resonance or 
voice. Articulation and resonance disorders arise from structural changes to the 
lips, tongue, palate, mandible, maxilla and velum, nasopharynx, and sinonasal 
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cavities. Voice disorders result from anatomic and/or physiologic changes to the 
larynx and vocal folds. 
Oral Cavity Cancer 
 The communication problems associated with oral cavity cancer depend 
on the type and extent of treatment. Non-surgical management of oral cancer 
usually results in only minor impairments to articulation and little effect on over-
all speech intelligibility. Pauloski and coworkers found that the effects of 
radiation therapy on speech are less severe than on swallowing Tissue changes 
that lead to fibrosis may limit speed of movement and lingual, labial, and/or 
mandibular strength, as well as range of notion. Resultant speech limitations 
include articulatory imprecision and sound substitutions. with extensive 
speaking rate of speech may be reduced and can become labored, thus 
interfering with the naturalness of speech. 
 Treatment may improve articulation and speech intelligibility. Logemann 
and associates demonstrated improved speech intelligibility with the use of 
range-or-motion exercises following oral and oropharyngeal tumor resection. 
Treatment is more likely to be successful if it is started early, and it produces 
little change if it is started longer than 1 year after surgery or radiation. 
 Prosthetic management improves speech and articulation following 
surgical resection. Prosthetic management of soft palate defects is directed to 
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separate oral and nasal cavities, increasing intraoral pressure and creating 
contact points for the tongue to improve precision of articulation. This results 
also in reduced nasal speech.  
 Hard palate defects treated prosthetically result in immediate separation 
of oral and nasal cavities, thus allowing for increased intraoral pressure and a 
greater number of contact points for the tongue.  
Tongue Defects  
 Total glossectomy is a severe detriment to speech production. The tongue 
is responsible for articulation of more than two thirds of the English language. 
The patient with a total glossectomy can be treated with a mandibular tongue 
prosthesis. The success of tongue rehabilitation depends on the presence of teeth 
to anchor the prosthesis. With proper dentition, the prosthesis can be anchored, 
and sounds such as/t, d, k, g, p, b/ can be articulated with improved precision. 
Leonard and Gillis reported significant improvement in both speech and 
swallowing when a prosthetic tongue was fitted properly in patients with total 
glossectomy 
 Partial glossectomy reconstruction consists of palatal augmentation  or 
mandibular augmentation. The augmentation prosthesis fills the void created by 
surgical excision. 
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SUMMARY 
 The management of dysphagia at the outset of the diagnosis of oral cancer 
has been shown to be unequivocally significant in the recovery process. 
Swallowing disorders are anticipated when key anatomic structures are removed 
or treated with radiation and/or chemotherapy. The critical valve-the vocal folds-
provides the necessary protection against aspiration; therefore, examination of 
the larynx and vocal folds is an essential aspect of management of patients with 
head and neck tumors, as well as those with swallowing difficulty after a 
cerebrovascular accident or surgery that may lead to high vagal lesions. 
 The otolaryngologist and the SLP are the key managers of swallowing 
disorders. Surgical and non surgical methods or rehabilitation provide the patient 
with improved swallow function and enhanced quality of life and speed the 
recovery process. There is a growing body of evidence to support the need for 
short-term as well as long-term management of swallowing disorders caused by 
anatomic changes, tissue changes, such as fibrosis long after radiotherapy and 
surgery. 
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                      Quality of Life in patients After Oral Resection 
Introduction 
 Why study quality of life (QOL) in head and neck cancer? Perhaps the 
dominant impetus is the disquieting truth that, when the traditional endpoints of 
survival and locoregional control are used, in many instances a significant 
difference between treatment options cannot be identified. Additionally, some 
studies support the contention that QOL of patients undergoing treatment for 
head and neck cancer is worse than that of patients with more common cancers. 
It is thus important to understand the conceptual foundations related to QOL 
measures so that they may be properly applied both in selection of treatment and 
in design of new clinical trials. 
 Head and neck cancer and its treatment affect some of the most 
fundamental functions of life, including eating, communication, and social 
interaction. Treatment may consist of surgery, radiation, and/or chemotherapy 
and is often functionally and cosmetically devastating. Facial disfigurement, 
speech impediment, difficulty with swallowing and chewing, loss of taste, and 
shoulder pain are common consequences of treatment. These disabilities can 
alter self-esteem, limit activity and employment, and decrease social interaction 
with family and friends. 
 Disease-free survival, overall survival, and tumor response rates are the 
traditional outcome measures that have been used to judge the efficacy of 
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treatment. Patients with stage I or II cancer of the head and neck generally have 
an 80% to 90% cure rate with minimal morbidity when managed by single-
modality surgical treatment. However, 5-year survival rates for patients with 
stage III and IV head and neck cancer are generally poor. Whether treatment is 
palliative or curative, the disability associated with treatment for advanced 
cancer often seems worse to the patient than the untreated cancer. For example, 
in his series of patients with stage IV head and neck cancer treated with curative 
or palliative intent, Burns reported that 42% of patients believed that ‘there was 
virtually no joy in life after treatment.” Gamba in his series of 66 patients treated 
surgically for advanced cancer of the head and neck without evidence of disease 
found that 18% of his subjects believed the disadvantages outweighed the 
advantages and that 30% believed the post-treatment difficulties were “too 
harsh”. In other words, the traditional outcome measures of treatment efficacy, 
such as tumor recurrence and survival time, are often meaningless to the patient. 
What matters is his or her ability to return to pre-illness function and 
psychosocial well-being. 
 Quality of life is the term used to describe the nontraditional outcome 
measures of functional status and psychosocial well-being. Especially in 
oncology, incorporation of QOL outcome measures to supplement standard 
clinical trial endpoints has recently increased. QOL endpoints and assessment 
have been used in clinical trials for advanced colorectal cancer. Hodgkin’s 
disease, advanced ovarian cancer, lung cancer, and chronic medical conditions 
 50 
such as hypertension, diabetes, and coronary artery disease. Furthermore, to 
promote the use of QOL outcome measures both the National Institutes of 
Health and the National Cancer Institute sponsored workshops on QOL 
assessment in 1990, including the recent conference on “Measuring and 
Reporting Quality of Life in Head and Neck Cancer”, sponsored by the National 
Institutes of Health, held in McLean, Virginia, in October 2002. This conference 
attracted an international audience representing quality of life researchers from 
20 countries. 
 QOL research is not lacking in the head and neck literature. A number of 
articles provide reviews of previous QOL studies and highlight the need for 
further QOL research. Particularly helpful general reviews are the contributions 
from Ringash and Bezjak and Long and associates. Head and neck cancer QOL 
research has primarily consisted of descriptive, retrospective studies. However, 
this situation is changing. In 1993, Browman and colleagues used a QOL 
instrument to measure acute morbidity due to radio-therapy in a prospective, 
randomized study of concurrent 5-fluorouracil (5-FU) and radiotherapy in the 
treatment of advanced head and neck cancer. Moreover, over the past few years, 
a number of general head and neck QOL questionnaires have been validated. 
Preliminary results indicate that these questionnaires are responsive to clinical 
change and could be incorporated into clinical trials. 
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Defining the concept and the content of quality of life 
 QOL is a multidimensional construct without a universally accepted 
definition. Ferrans and Powers define QOL as a “person”s sense of well-being 
that stems from satisfaction or dissatisfaction with the areas of his life that are 
important to him. According to Cella, QOL is a “patient’s appraisal of and 
satisfaction with current level of functioning as compared to what they perceive 
to be possible or ideal. Crucial to any definition is the recognition that different 
people have different values that cause aspects of their lives to have different 
impacts on their QOL. For example, a disease or treatment that would interfere 
with an individual’s ability to work or to be active would have a more profound 
impact on the QOL of an individual who was employed and enjoyed exercising 
regularly than on the QOL of an individual who was retired and led a relatively 
sedentary life. It is also conceptually important to acknowledge that individual 
QOL varies over time according to a wide variety of extrinsic and intrinsic 
factors. 
 To gain the advantages of both types of measures, investigators have 
recently synthesized both approaches into one measurement strategy, called a 
modular approach to QOL assessment. IN this approach, a set of core disease-
specific questions is supplemented by a set of site-or treatment-specific 
questions. The Functional Assessment of Cancer Therapy (FACT) and European 
Organization for Research and Treatment of Cancer (EORTC) scales are 
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examples of the modular approach. These instruments have a core cancer QOL 
measure with modules for different types of cancer, such as breast, lung, and 
head and neck cancer. General health questionnaires can be used concurrently 
with the core and modular questionnaires to obtain additional QOL information. 
As has been noted by Osaba, there is ample evidence “that some 
multidimensional measures of HQL (health-related QOL) may be more accurate 
predictors of survival than either KPS (Karnofsky Performance Status) or the 
Eastern Cooperative Oncology Group (ECOG) performance status. If this is true, 
a disease-specific head and neck QOL assessment could be an important 
stratification variable for prospective randomized trials in head and neck cancer. 
Head and Neck-Specific Questionnaires 
 Many head and neck QOL questionnaires have been developed for use 
across the broad spectrum of head and neck cancers: 
 List’s Performance Status Scale for Head and Neck Cancer 
Patients,  
 The EORTC Core QOL Questionnaire with a Head and Neck 
Module, 
 The University of Washington (UW) QOL Questionnaire,  
 Cella’s FACT Scale with a Head and Neck Module, and 
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 The University of Michigan Head and Neck Specific QOL 
Instrument are among these. 
List’s Performance Status Scale for Head and Neck Cancer Patients. 
List’s Performance Status Scale is a clinician -rated tool for measuring the 
unique disabilities of head and neck cancer patients in the areas of eating and 
speaking Patients receive a functional rating score in three subscales-eating in 
public, understandability of speech, and normalcy of diet. In each subscale, a list 
of items is arranged in a hierarchy, with normal function and total incapacitation 
receiving scores of 100 and 0, respectively. Reliability and validity were 
demonstrated in 181 patients with cancer of the head and neck, representing a 
range of diagnoses such as cancer of the oral cavity, pharynx, larynx, and other 
head and neck sites. Furthermore, when these patients were divided into four 
groups based on the extent of their surgery (wide local excision, partial 
laryngectomy, total laryngectomy, and flap reconstruction), significant group 
differences were found in all three performance subscales. 
 EORTC Core-QOL Questionnaire with a Head and Neck Module. A 
disease-specific module for cancer of the head and neck to supplement the QLQ-
C30 has recently been validated. The module consists of 21 items measuring 
disease-related symptoms and treatment-related adverse effects. These items 
include questions concerning problems with tasting, swallowing, talking, 
producing saliva and mucus, and breathing through the nose. The module was 
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completed by 126 patients. Thirty-three percent of patients had cancer in the oral 
cavity, 13% in the pharynx, 19% in the larynx, 18% in the skin, and the 
remaining 18% in the salivary glands, paranasal sinuses, thyroid gland, or 
cervical lymph nodes without a known primary. The EORTC QLQ-C30 with a 
head and neck module was found to discriminate between groups of patients 
before, during, and after treatment with radiation, and between acute, sub acute, 
and late disease - and treatment - related symptoms and toxicity. For example, 
problems with soreness in the mouth, swallowing, and salivation/mucus 
production were worst halfway through the radiation course, while change in 
taste was greatest immediately after treatment completion. The questionnaire’s 
high acceptance and compliance rates among patients add to its utility as a 
practical QOL instrument. 
 Before the publication of the EORTC head and neck module, Jones and 
associates developed a head and neck QOL questionnaire based on the EORTC 
core questionnaire to which a specific head and neck module had been added. In 
the questionnaire, 14 questions specific to cancer of the head and neck were 
scored on an interval from 0 to 3. Responses to each question ranged from “not 
at all” to “very much.” In Jones’ study, 48 patients who had under-gone surgical 
treatment for cancer of the head and neck completed the questionnaire (a 
response rate of 98%). For analysis, the patients were divided into five groups: 
laryngectomy (25), craniofacial procedure (11), pharyngo-
laryngoesophagectomy (5), “other operation” (4 patients who underwent a 
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hemiglossectomy, 3 tonsillectomy, and 2 thyroidectomy), and patients with 
clinical recurrence. In each group, different problem areas were identified. 
Laryngectomy patients reported speech difficulties and hyposmia. Craniofacial 
patients described visual problems, headaches, and a diminished sense of taste 
and smell. Pharyngolaryngoesophagectomy patients described eating and 
speech-related problems. Patients with recurrence reported problems with 
speech. Self-consciousness, smell, taste, and eating. In Jones opinion, the results 
indicate that additional studies should use the EORTC questionnaire to increase 
the clinician’s understanding of functional problems, which in turn would aid 
rehabilitation efforts. 
UW QOL Questionnaire. The UW QOL questionnaire was designed to 
be specific for head and neck patients. It is patient-administered and generally 
can be completed in less than 5 minutes. The scale comprises 10 categories, each 
of which describes important daily living dysfunctions or limitations about 
which patients complain, that result from cancer of the head and neck or its 
treatment effects. Each of the nine categories includes several options that allow 
the patient to describe his or her own current functional status. 
 The highest level, or “normal” function, is assigned 100 points, whereas 
the lowest level, or greatest dysfunction, is scored 0 points. Each category 
contributes equally to the final score of the questionnaire of 1000 points. This 
questionnaire was administered to 75 head and neck cancer patients on three 
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separate to 75 head and neck cancer patients on three separate occasions: (1) 
several days preoperatively, (2) immediately postoperatively, (3) and 3 months 
postoperatively. Patients were grouped according to their clinical stage (T1, T2, 
T3, or T4). The questionnaire was found to be sensitive enough to detect not 
only the expected large differences in QOL for T3 - and T4- stage cancer 
patients after treatment, but also the more subtle changes that may occur in T1-
T2-stage patients. 
 The UW QOL instrument was further assessed for internal consistency 
with the use of data collected from 550 patients. Based on this analysis, the 
domains have been modified to eliminate “employment” and “dryness,” and. a 
global QOL inquiry has been added.   
Recently, Rogers and colleagues analyzed the addition of two questions 
regarding mood and anxiety. Their results indicate that the addition of these two 
questions has strengthened the UW QOL instrument by providing previously 
absent probes in the psychosocial realm. 
Quality of life assessment in head and neck cancer 
 Two types of QOL studies have been done in cancer of the head and 
neck-those that report assessment strategies and QOL instruments and those that 
document QOL in specific patient populations. The Purpose of QOL research in 
head and neck cancer has been threefold: (1) to use QOL as an outcome measure 
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of treatment, (2) to assess the rehabilitation needs of patients, and (3) to 
determine the pretreatment QOL of patients so that QOL can be used as a 
predictor of prognosis. Site-specific and treatment-specific QOL questions 
account for the majority of QOL research in head and neck cancer. Particularly 
in cases where different treatments have nearly equivalent cure rates but 
different functional problems, questions of QOL have been raised to guide the 
selection of treatment. This particularly applies to treatment decisions for 
patients with cancer of the larynx. 
 Komisar published the first studies of the functional results of mandibular 
reconstruction for patients who had undergone composite resection of 
oropharyngeal cancer. In his 1990 series, seven patients underwent 
reconstruction with a metal plate and a free bone graft taken from the iliac crest. 
One patient underwent reconstruction with only a metal plate. In the 
reconstructed group, two patients also received myocutaneous flaps. In the group 
of eight patients who did not undergo mandibular reconstruction, seven received 
myocutaneous flaps for oral closure. The functions of deglutition, mastication, 
and cosmesis were compared between patients with and without reconstruction. 
There was no significant difference in deglutition. Mastication was worse and 
cosmesis was improved among the patients with reconstruction. Patients with 
reconstruction also had a greater number of hospitalizations secondary to 
complications from the reconstructive procedure. Kosimar concluded that 
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aggressive surgical reconstruction of the mandible for lateral defects does little 
to improve the QOL of patients with oral pharyngeal cancer. 
 In 1991, Urken and colleagues demonstrated the functional advantages of 
free-tissue transfer in oromandibular reconstruction. using a number of tests to 
assess overall well-being, cosmesis, deglutition, oral competence, speech, length 
of hospitalization, masticatory function, and dental rehabilitation, Urken 
compared 10 patients who underwent one-state oromandibular reconstruction 
using the iliac crest-internal oblique free flap and dental rehabilitation with 
osseointegrated implants versus 10 patients with similar soft tissue and bone 
defects who underwent no bony reconstruction of the mandible. In the group of 
patients with non reconstructed mandibles, three required a pectoralis major flap 
for oral cavity reconstruction. One patient had reconstruction with a hemitongue 
flap. The defect in the remaining six patients was closed primarily. In almost all 
functional and psychosocial categories, patients who had undergone 
reconstruction had higher scores. The average length of hospitalization for 
patients with reconstruction (20.1 days) was not significantly higher than the 
length of hospitalization (19.7 days) for patients who had not under-gone 
reconstruction. In addition, patients with mandibular reconstruction achieved a 
functional level closer to that of their pre-disease state and were able to resume 
employment and social activities more frequently than patients who had not 
undergone reconstruction. 
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 Urken’s study represents the type of critical analysis of post-treatment 
function that is necessary for the evaluation of surgical therapy. Without such 
analysis, treatment decisions are based on the surgeon’s preference. 
 Thus, the present and future challenge of head and neck research is to 
work toward the routine inclusion of QOL outcome measures in clinical trials. 
QOL might prove to be the most sensitive and powerful measure of treatment 
efficacy. 
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